FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource CodeSystem/FHIR Server from package hl7.terminology.r4b#6.0.2 (188 ms)

Package hl7.terminology.r4b
Type CodeSystem
Id Id
FHIR Version R4B
Source http://terminology.hl7.org/http://terminology.hl7.org/6.0.2/CodeSystem-v3-rxNorm.html
Url http://www.nlm.nih.gov/research/umls/rxnorm
Version 3.0.1
Status active
Date 2020-11-03
Name RxNorm
Title RxNorm
Experimental False
Realm uv
Authority hl7
Description RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software, including those of First Databank, Micromedex, and Gold Standard Drug Database. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary. RxNorm now includes the United States Pharmacopeia (USP) Compendial Nomenclature from the United States Pharmacopeial Convention. USP is a cumulative data set of all Active Pharmaceutical Ingredients (API).
Copyright Using RxNorm codes of type SAB=RXNORM as this specification describes does not require a UMLS license. Access to the full set of RxNorm definitions, and/or additional use of other RxNorm structures and information requires a UMLS license. The use of RxNorm in this specification is pursuant to HL7's status as a licensee of the NLM UMLS. HL7's license does not convey the right to use RxNorm to any users of this specification; implementers must acquire a license to use RxNorm in their own right.
Content not-present

Resources that use this resource

CodeSystem
http://fhir.org/guides/cdc/opioid-mme-r4/CodeSystem/CDCMMEClinicalConversionFactors CDC MME Clinical Conversion Factors
http://fhir.org/guides/cdc/opioid-mme-r4/CodeSystem/cfct-example-CDCMMEClinicalConversionFactors Example CDC MME Clinical Conversion Factors
http://profiles.ihe.net/PCC/RIPT/StructureDefinition/IHE.PCC.RIPT.Mediaction RIPT Mediaction
http://hl7.org/fhir/uv/vulcan-rwd/ValueSet/ExampleClopidogrelCodes ACS Example Clopidogrel Codes
http://hl7.org/fhir/uv/vulcan-rwd/ValueSet/ExamplePrasugrelCodes ACS Example Prasugrel Codes
http://hl7.org/fhir/uv/vulcan-rwd/ValueSet/ExampleTicagrelorCodes ACS Example Ticagrelor Codes
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-aldosterone Aldosterone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-aspirin Aspirin Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-betamethasone-exclude Exclude Betamethasone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-betamethasone Betamethasone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-bromfenac-exclude Exclude Bromfenac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-bromfenac Bromfenac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-bumetanide Bumetanide Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-celecoxib Celecoxib Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cloprednol Cloprednol Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cortisone Cortisone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cortivazol Cortivazol Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude Exclude cyclosporine Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine Cyclosporine Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-deflazacort Deflazacort Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-desoxycorticosterone Desoxycorticosterone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-dexamethasone-exclude Exclude Dexamethasone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-dexamethasone Dexamethasone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-dexlansoprazole Dexlansoprazole Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-diclofenac-exclude Exclude Diclofenac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-diclofenac Diclofenac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-diflunisal Diflunisal Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-digoxin Digoxin Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-eplerenone Eplerenone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-esomeprazole Esomeprazole Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ethacrynate Ethacrynate Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-etodolac Etodolac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-fenoprofen Fenoprofen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-fludrocortisone Fludrocortisone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-fluocortolone-exclude Exclude Fluocortolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-fluocortolone Fluocortolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-flurbiprofen-exclude Exclude Flurbiprofen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-flurbiprofen Flurbiprofen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-furosemide Furosemide Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-hydrocortisone-exclude Exclude Hydrocortisone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-hydrocortisone Hydrocortisone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ibuprofen-exclude Exclude Ibuprofen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ibuprofen Ibuprofen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-indomethacin Indomethacin Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ketoprofen-exclude Exclude Ketoprofen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ketoprofen Ketoprofen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ketorolac-exclude Exclude Ketorolac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ketorolac Ketorolac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-lansoprazole Lansoprazole Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-mefenamate Mefenamate Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-meloxicam Meloxicam Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-meprednisone Meprednisone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-methylprednisolone-exclude Exclude Methylprednisolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-methylprednisolone Methylprednisolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-misoprostol Misoprostol Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nabumetone Nabumetone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-naproxen Naproxen Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac-exclude Exclude Nepafenac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac Nepafenac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-omeprazole Omeprazole Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-oxaprozin Oxaprozin Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-pantoprazole Pantoprazole Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-paramethasone Paramethasone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-piroxicam-exclude Exclude Piroxicam Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-piroxicam Piroxicam Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-prednisolone-exclude Exclude Prednisolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-prednisolone Prednisolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-prednisone Prednisone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-prednylidene Prednylidene Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rabeprazole Rabeprazole Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone-exclude Exclude Rimexolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone Rimexolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-spironolactone Spironolactone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-sulindac Sulindac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-tolmetin Tolmetin Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-topicaldiclofenac Topical Diclofenac Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-torsemide Torsemide Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-triamcinolone-exclude Exclude Triamcinolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-triamcinolone Triamcinolone Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-trilostane Trilostane Medications Value Set
http://hl7.org/fhir/uv/pddi/ValueSet/valueset-warfarin Warfarin Medications Value Set
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubjectObservationValue KnowledgeSubjectObservationValue
http://cqframework.org/cpg-example-opioids/ValueSet/opioids-with-ambulatory-abuse-potential Opioids with Ambulatory Abuse Potential
http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips Medications - example (IPS)
http://fhir.org/guides/cdc/opioid-cds/ValueSet/amphetamines-class-medications Amphetamine class medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/benzodiazepine-medications Benzodiazepine medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/buprenorphine-and-methadone-medications Buprenorphine and Methadone medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/cns-depressant-medications CNS depressant medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/extended-release-opioid-with-ambulatory-misuse-potential Extended release opioid with ambulatory misuse potential
http://fhir.org/guides/cdc/opioid-cds/ValueSet/fentanyl-type-medications Fentanyl-type medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/methadone-medications Methadone medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/naloxone-medications Naloxone medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/non-opioid-cns-depressant-medications Ambulatory setting non-opioid CNS depressant medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/non-synthetic-opioid-medications Non-synthetic opioid medications
http://fhir.org/guides/cdc/opioid-cds/ValueSet/opioid-analgesics-with-ambulatory-misuse-potential Opioid analgesics with ambulatory misuse potential
http://fhir.org/guides/cdc/opioid-cds/ValueSet/synthetic-opioid-medications Synthetic opioid medications
http://hl7.org/fhir/us/davinci-drug-formulary/ValueSet/NonPackSemanticDrugVS Non-Pack Semantic Drug Codes
http://hl7.org/fhir/us/davinci-drug-formulary/ValueSet/SemanticDrugFormGroupVS Semantic Drug Form Group Codes
http://hl7.org/fhir/us/davinci-drug-formulary/ValueSet/SemanticDrugVS Semantic Drug Codes
http://hl7.org/fhir/us/registry-protocols/ValueSet/Antiarrhythmics All Antiarrhythmics
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medication-rxnorm-tw RxNorm藥品代碼值集
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclass DataElement SDC Object Class
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclassproperty DataElement SDC Object Class Property
http://hl7.org/fhir/uv/saner/ValueSet/Remdesivir Remdesivir
http://fkcfhir.org/fhir/ValueSet/fmc-allergy-code-vs Fresenius Allergy Code Value Set
http://fkcfhir.org/fhir/ValueSet/fmc-medication-code-vs Fresenius Medication Code Value Set
http://moh.gov.vn/fhir/core/ValueSet/vn-medication-code ValueSet dành cho Mã dược phẩm
http://fhir.health.gov.il/ValueSet/il-core-medication-code ILCore Medication Code
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12.html ImagingContrastAgent
http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3850.html ContrastBolusSubstance
http://terminology.hl7.org/ValueSet/v3-KnowledgeSubjectObservationValue KnowledgeSubjectObservationValue
http://hl7.org/fhir/us/carin-rtpbc/ValueSet/rtpbc-prescribable-product-code RTPBC Prescribable Product Code Value Set
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.144 Fertility Enhancing Drugs (NCHS)
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.23 Augmentation of Labor - Medication (NCHS)
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.26 Epidural Anesthesia - Medication (NCHS)
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.28 Spinal Anesthesia - Medication (NCHS)
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.3 Antibiotics (NCHS)
http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.38 Glucocortico Steroids (NCHS)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.16 Medication Brand Name Value Set
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1103 Semantic Clinical Drug (Ingredient plus strength and dose form)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1104 Semantic Clinical Drug Form (Ingredient plus dose form)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3120 Antibiotic Received (Pertussis)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3147 Medication Received (VZ)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3218 Medication Treatment (TB)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3311 Medication Prophylaxis (Malaria)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3312 Medication Treatment (Malaria)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7055 Antituberculosis Drugs (TB)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7103 VPD Laboratory Coded Observation
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7194 Drugs Used (STD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7475 Epidural/Spinal Anesthesia - Medication (NCHS)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7539 Medication Treatment (Babesiosis)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7619 Antibiotics (FDD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7620 Antacids (FDD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7635 Medication Administered (FDD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7693 Antibiotic Received (RIBD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7700 AR Agent (RIBD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7759 Medication (TB)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7834 Medication Received (TBRD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7839 Medication Received (Lyme)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7923 Medication Treatment (STD)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7954 Medication Administered (Hansen)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7961 Medication (Leptospirosis)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7963 Medication Administered (Anthrax)
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7972 Medication (Brucellosis)
http://fhir.org/guides/argonaut/ValueSet/medication-codes Medication Clinical Drug (RxNorm)
http://fhir.org/guides/argonaut/ValueSet/substance-rxnorm DAF Substance RxNorm Codes
http://capable-project.eu/data/fhir/ValueSet/medical-prescriptions Medical prescriptions
http://hl7.org/fhir/uv/ips/ValueSet/medication-example-uv-ips Medications (example) - IPS
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclass DataElement SDC Object Class
http://hl7.org/fhir/ValueSet/dataelement-sdcobjectclassproperty DataElement SDC Object Class Property
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3 selected first line medications for pain control
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3 selected muscle relaxants for pain control
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3 Selected topical agents for pain control
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2 selected non opioids for moderate to severe pain
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2 Selected opioids for moderate to severe pain
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1 Opioids used for pain control
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.2 All prescribable opioids used for pain control including Inactive Medications
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251 Cerumenolytics
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319 Intranasal Antihistamines
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320 Mast Cell Stabilizers
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321 Ophthalmic Antihistamines
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315 Intranasal Corticosteroids
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287 Oral Second Generation and Less Sedating Antihistamines
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266 Leukotriene antagonist
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653 Fidaxomicin
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654 Proton Pump Inhibitors not including for H. pylori treatment
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662 Metronidazole Systemic
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663 Vancomycin non injectable
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658 Antiperistaltic agents to avoid in C. diff
http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734 Systemic Antimicrobial Medications not used for CDI
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1 Substance Reactant for Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2 Clinical Substance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.4 Medication Clinical Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.5 Medication Clinical Brand specific Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.7 Clinical Drug Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.8 Vaccine Clinical Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16 Low Intensity Statin Therapy/Branded
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17 Moderate Intensity Statin Therapy/Branded
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18 High Intensity Statin Therapy/Branded
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26 Nonopioid pain medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303 Statin Combinations
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313 Statin Allergen Grouping
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319 Steward Transfer Test
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320 Opioids ATCPROD N02A
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34 Opioid pain medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42 Naloxone and Nalmefene medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43 Benzodiazepine medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44 Stool softeners and laxatives
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54 Adjuvant pain medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558 Acute Cluster Headache Medication (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559 Long Term Preventive Medication for Cluster Headache
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561 Oral Steroid for Cluster Headache
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569 Migraine Preventive Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601 Acute Migraine Attack Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605 NSAID OTC Migraine Attack Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643 Antiplatelets
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644 Anticoagulants
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645 Statin Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651 Galcanezumab (RxNorm)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652 Lithium (RxNorm)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653 Verapamil
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654 Long term preventive medications for cluster headache
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655 Short term preventive medication for cluster headache
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656 Zolmitriptan
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657 Sumatriptan
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658 Dihydroergotamine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659 Acute cluster headache medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39 Low Dose Unfractionated Heparin for VTE Prophylaxis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41 Glycoprotein IIb IIIa Inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55 Oxytocin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56 Dinoprostone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241 Schedule II, III and IV Opioid Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269 Medications for Opioid Use Disorder (MOUD)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107 Low Intensity Statin Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543 Bevacizumab injection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.544 Ranibizumab injection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.545 Aflibercept injection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557 Corticosteroids for Injection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582 Corticosteroids for Injection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.97 High Intensity Statin Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.98 Moderate Intensity Statin Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1072.34 Primidone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.146 Long Acting Muscarinic Antagonists (LAMA)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168 medications_COPD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.186 Beta blockers GDMT for heart failure
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189 SGLT2i
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.238 MRA mineralocorticoid receptor antagonists
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.369 Candesartan
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.377 Valsartan
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.412 Statin Moderate Intensity
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.438 medications_T2DM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.45 ACE inhibitor allergy/intolerance codes
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.473 Tetanus toxoid, diphtheria (Td) Vaccine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.48 ACE inhibitor allergy/intolerance codes
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.527 OCS_Prednisone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.528 High Dose Non Combo ICS Adult
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.529 Medium Dose Non Combo Asthma ICS Adult
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.530 Low Dose Non Combo ICS
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.531 Anti IgE Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532 IL5 Antagonists
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.533 Mast cell stabilizers for asthma
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.552 Triptans
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.553 CGRP receptor antagonists
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554 Ditans
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.555 Ergots
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.556 Migraine specific NSAIDs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.557 OTC migraine analgesics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.558 Butalbital analgesics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.559 medications_migraine_acute
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565 Triptan Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.569 Allergen Immunotherapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.578 PIM_Schedule V
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.580 PIM_Acarbose
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581 PIM_Avandamet
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.582 PIM_Dulaglutide
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.583 PIM_Glimepiride
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.585 PIM_Glucophage
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.587 PIM_Glucovance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.588 Glyburide PIM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.590 Alpha glucosidase inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.595 ICS Low
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.596 ICS Medium
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.597 ICS High
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.598 Low Dose ICS Formoterol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.604 PIM_Glyburide
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.605 PIM_Pioglitazone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.606 PIM_Semaglutide
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.607 PIM_Linagliptin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.609 Macrolide_Azithromycin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.61 Secondary antihypertensives
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.610 Long Acting Beta Agonists (LABA) Non_Formoterol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.615 medications_Asthma
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.617 HighICS_LABA_NonFormoterol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.619 ICS_LABA_LAMA
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.620 Low Dose ICS_LABA_Non Formoterol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.621 Medium ICS_LABA Non Formoterol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.642 T2DM_Medications Allergy RXNORM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646 T2DM_Medication Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647 Statins Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649 ACE Inhibitors Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650 ARB Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652 Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653 Long Acting Beta Agonists (LABA) Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654 BetaBlocker NonCS Secondary Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656 Mineralocorticoid receptor antagonists (MRA) Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657 Eplerenone Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658 Spironolactone Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659 SGLT2i Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660 Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661 Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665 Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666 Human Papillomavirus (HPV) vaccine Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.667 Herpes Zoster Vaccine Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670 Pneumococcal Vaccine Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671 Inhaled Corticosteroids(ICS) Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.672 LABA(Formoterol only)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.674 PIM_Tirzepatide
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675 GLP1RA Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.677 PIM_H2_Antagonists
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.678 SGLT2i DM CKD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679 SGLT2i DM ASCVD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680 GLP1RA DM ASCVD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.683 PIM_Allopurinol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.684 GlumetzaSubstitution
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.685 MetforminER500mg
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.686 PIM_Metformin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.687 PIM_Glipizide
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.689 PIM_Glipizide_Glyburide_Glimepiride
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.690 PIM_Insulin_Meglitinides
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691 PIM_Glyxambi
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.692 PIM_Farxiga
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.693 PIM_Invokana
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.694 PIM_Jardiance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695 PIM_Invokana_Jardiance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696 Reclast
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.697 LAMA_LABA Combination 1 Inhaler
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.698 PIM_Contraceptives
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.699 Selected Oral Antiemetics for Migraine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.702 PIM_SSRIs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.703 PIM_SNRIs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.704 PIM_NRIs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.705 PIM_TCAs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.706 PIM_Citalopram
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.707 PIM_Hydroxyzine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.708 PIM_Buspirone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.709 PIM_Bupropion
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.710 PIM_Mirtazapine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.711 PIM_Trazodone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.714 PIM_Gabapentin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.715 PIM_Allergy_Nasal_Sprays
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.716 PIM_Allergy_Oral_Meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.717 PIM_Allergy_Nasal_Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.719 OCS_Prednisolone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.72 Inhaled corticosteroids (IC)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.720 COPD_Ofloxacin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.721 COPD_Ciprofloxacin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.722 COPD_Doxycycline
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724 Macrolides Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728 Tetracycline Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730 Fluoroquinolone Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.731 Penicillin Allergy RXNORM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733 Penicillin Allergy Intolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.734 PIM_Metformin_Single_Ingredient_Only
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.735 PIM_Metformin_Combo_Ingredient_Only
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.779 PIM_Potassium_Supplements
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.780 PIM_PPIs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.781 PIM_Migraine_Medications_Abortive
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.782 PIM_Migraine_Medications_Preventive
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.783 PIM_Bisphosphonates
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.784 PIM_BPH_Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.785 PIM_Thyroid_Replacement_Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.786 PIM_Overactive_Bladder_Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.787 PIM_Topical_Acne_Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.788 PIM_Antidepressant_Anxiolytic_Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.823 Aminoglycosides
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.824 Carbapenems
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.826 Monobactams
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.827 Penicillins
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.828 Antimycobacterials
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.829 Beta_lactamase
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.830 Cyclic lipopeptides
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.831 Lincosamides
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.832 Macrolides
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.833 Amphenicol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.834 Oxazolidinones
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.835 Fluoroquinolones
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.836 Sulfonamides
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.837 Tetracyclines
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.838 Phosphonics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.839 Pleuromutilin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.840 Streptogramins
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.841 Lipoglycopeptides
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.842 Nitroimidazoles
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.843 PIM_Hyd_Bus_Mir_Tra
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.844 Nitrofurans
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.845 Rifamycins
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.846 Glycylcycline
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.847 Pyrimidines
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.849 Antibiotics oral and parenteral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.85 PCSK9i
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.850 Medications_hyperkalemia
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.855 Medications_Chronic Hyperkalemia
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.858 PIM_Alpha_Blockers_2
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.870 PIM_Triptans
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.871 ICS_SABA Reliever
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.873 PIM_Asthma_COPD_Meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876 Alpha Glucosidase AllergyIntolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883 DPP4i AllergyIntolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890 Meglitinide AllergyIntolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891 Sulfonylurea AllergyIntolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895 Thiazolidinedione AllergyIntolerance
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.896 PIM_Beta_Blockers
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.897 PIM_CCB_DHPs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.898 PIM_Loop_Diuretics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.899 PIM_Inhaled_Corticosteroids_(ICS)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.900 PIM_Leukotrienes
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.901 OIA_Asthma_COPD_Meds_Inhalers
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.902 OIA_Asthma_COPD_Meds_Nebulizers
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.903 OIA_Asthma_COPD_Meds_Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.904 OIA_GLP1_Injectables
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.905 OIA_Insulin_Injectables
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.906 OIA_Oral_Hypoglycemics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.907 OIA_DM1_DM2_Meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.908 Medium Dose ICS Formoterol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.909 High Dose ICS Formoterol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.926 Canagliflozin meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.927 Empagliflozin meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.928 Dapagliflozin meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.929 Ertugliflozin meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.930 Dulaglutide meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931 Liraglutide meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.932 Semaglutide SC meds
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933 T2DM meds benefitting ASCVD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934 T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.935 T2DM meds benefitting CKD stage 5
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.936 T2DM meds benefitting HF with eGFR >= 20 mL/min
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.944 OIA_Bisoprolol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.947 OIA_Antihypertensive_Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.959 ACEi for HFrEF
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.960 ARB for HFrEF
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.961 OIA_AntiHTN_Meds_Inclusion_List
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.962 OIA_Thiazide_Diuretics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42 Statin Allergen
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50 Rivaroxaban for VTE Prophylaxis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.51 Prasugrel
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52 Pharmacological Contraindications For Antithrombotic Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.61 Antithrombotic Therapy Antiplatelet
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62 Antithrombotic Therapy for Ischemic Stroke
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.146 Buprenorphine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.166 Codeine Schedule II and III
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.167 Alfentanil
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.168 Remifentanil
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.169 Sufentanil
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.151 Cisplatin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.154 Gemcitabine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.155 Docetaxel
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.165 Carboplatin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.166 Paclitaxel
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168 Doxorubicin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169 Irinotecan Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179 Bevacizumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.181 Methotrexate
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.196 Ixabepilone Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.197 Goserelin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200 Epirubicin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.204 Letrozole
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.206 Exemestane
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.209 Fluorouracil
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210 Capecitabine Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222 Aprepitant Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223 Fosaprepitant Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.257 Colorectal Cancer Chemotherapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332 Daunorubicin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.449 Opioids
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.492 Pharmacological interventions for depression
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560 Rolapitant Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602 Neurokinin 1 Receptor Antagonist
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604 Serotonin Receptor Antagonist
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61 Cetuximab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1 Schedule IV Benzodiazepines
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.26 C2S HIV/AIDS Information Sensitivity
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.3 C2S Alcohol Use Disorders
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.35 C2S Mental Health Disorders
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.52 C2S Tobacco Use Disorders
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58 C2S Sensitive Categories
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1078 Opioid Overdose and Poisoning (Naloxone) (RxNorm)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1594 HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1595 HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1597 HIV Infection (ARV Combination Treatment for HIV) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1598 HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600 HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1618 Smallpox Vaccine (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1634 Sofosbuvir Velpatasvir Combination (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1912 Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1913 Penicillin G [Procaine] [Injectable] (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2142 Tuberculosis (Linezolid) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2143 Tuberculosis (Pretomanid) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2144 Tuberculosis (Bedaquiline) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2362 Tuberculosis (Ethambutol) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2363 Tuberculosis (Isoniazid [INH]) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2364 Tuberculosis (Pyrazinamide [PZA]) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2365 Tuberculosis (Rifabutin) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2366 Tuberculosis (Rifampin) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2367 Tuberculosis (Rifapentine) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.741 Hepatitis B Immune Globulin (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.844 Tuberculosis (Second Line Drugs for Treatment) (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.991 Rifampin (RXNORM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.130 Anticoagulants for VTE Prophylaxis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.131 Anticoagulants for Indications Other than VTE Prophylaxis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.32 Immunosuppressive Drugs for Urology Care
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.4 BCG Bacillus Calmette Guerin, Tice
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.48 Androgen deprivation therapy for Urology Care
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5 BCG Bacillus Calmette Guerin, Connaught
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.52 BCG Bacillus Calmette Guerin for Urology Care
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.60 Chemotherapy Agents for Advanced Cancer
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.43 Analgesics for Acute Pain
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.57 Aldosterone Receptor Blocker for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.58 Alpha Blocker for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.59 Angiotensin Converting Enzyme Inhibitor for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.60 Angiotensin II Receptor Blocker for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.61 Beta Blocker for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.62 Calcium Channel Blocker Dihydropyridine for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.63 Calcium Channel Blocker Non Dihydropyridine for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.64 Central Acting for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.65 Direct Renin Inhibitor for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.66 Loop Diuretic for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.67 Neuronal Blocking Agent for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.68 Potassium Sparing Diuretic for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.69 Thiazide Diuretic for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.70 Vasodilator for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.73 Analgesics for Acute Pain (Oral Route)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.74 Analgesics for Acute Pain (Parenteral Route)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.75 Analgesics for Acute Pain (Non Oral Enteral/Mucosal Routes)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.77 Antihypertensive Medication Classes
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.129 Contraceptive Ring RXNORM Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.130 Contraceptive Implants RXNORM Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.131 Injectable Contraceptive RXNORM Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.132 Oral Contraceptive Pills RXNORM Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.76 Contraceptive Patch RXNORM Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.85 Intrauterine Devices RXNORM Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.4 Thrombolytic medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.1 Ezetimibe Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.10 Antihypertensive Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.139 AHA GWTG Anti Obesity Pharmacotherapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.16 Antihypertensive Fixed Dose Combination Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2 PCSK9 Inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.20 CCB and Thiazide and Thiazide Like Diuretics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27 ARNI Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29 MRA Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.30 SGLT2 Inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.35 Aspirin or Clopidogrel
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.43 SGLT2 Ingredients
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.44 MRA Ingredients
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.72 ARNI Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.90 Non Steroidal Mineralcorticoid Receptor Antagonist
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.91 Glucagon like peptide 1 medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.1 Common drug substances for allergy and intolerance documentation
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.7 Common substances for allergy and intolerance documentation
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.8 Common substances for allergy and intolerance documentation including refutations
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.58 Diabetes Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.76 Fidaxomicin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.77 Vancomycin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.78 Metronidazole
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.79 Fidaxomicin, Vancomycin, and Metronidazole
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.85 Baloxavir
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.86 Peramivir
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.87 Zanamivir
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.90 NHSN LTC AU Antimicrobial Agents
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1354 Cefixime preparations for oral administration
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1370 Beta lactam ingredients for allergy determination RXNORM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158 Multiple Myeloma Regimen Drugs
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.226 Opioids, All
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.393 Hypoglycemics Severe Hypoglycemia
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.394 Hypoglycemics Treatment Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4436 Gentamicin medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4437 Azithromycin medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4448 Lidocaine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4469 Cabotegravir Injectable Products
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4470 Emtricitabine oral for HIV PrEP
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4502 Ceftriaxone all code types
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491 Medium Dose ICS Formoterol Preparations
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.495 ICS LABA LAMA Preparations
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93 CPIC RxNORM abacavir SCDG
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.94 CPIC RxNORM allopurinol SCDG
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.95 CPIC RxNORM amitriptyline SCDG
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96 CPIC RxNORM atazanavir SCDG
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.97 CPIC RxNORM atomoxetine SCDG
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.99 CPIC RxNORM capecitabine SCDG
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.12 Opioid (Oral Tablets and Patches only)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.19 Anticoagulant Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.20 Anticoagulant Medications, Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.21 Anticoagulant Medications, Injection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.29 Fall Risk Increasing Drugs (FRIDs)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.41 TricyclicAntidepressants
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.42 Benzodiazepines
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.43 LoopDiuretics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.44 Antiepileptics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.45 Antipsychotics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.46 Opioid Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.48 Anticoagulant Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.50 Bisphosphonate Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.101 Local Anesthetics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.102 Ophthalmic Epinephrines
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.103 Inhaled Epinephrines
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.104 Clopidogrels
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.105 Cytochrome P450 2C19 inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.106 Cytochrome P450 2C9 inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.107 Aspirin Ingredient and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109 Oral Anticoagulant Ingredients and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.110 Corticosteroid Ingredients and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.111 Antidepressant Ingredients and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.112 PPI and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.113 Antiplatelet Ingredients and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.114 NSAIDs Ingredients and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117 Clopidogrel Ingredients and Risk of GI Bleeding
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.24 Oxycodones
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.192 Immunosuppressive Medication RxNorm
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.193 Medication Supporting Immunosupressive Medication RxNorm
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.197 Turalio
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.85 Insulin Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.176 Methotrexate Injection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.177 Mifepristone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.178 Misoprostol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.179 Abortion Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.183 Clomiphene (Selective Estrogen Receptor Modulator / SERM)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.184 Letrozole (Aromatase inhibitor)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.185 Infertility, Female Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.209 Transfeminine Regimens, Antiandrogens
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.210 Transfeminine Regimens, Estrogens
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.211 Transfeminine Regimens, GnRH Agonists
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.212 Transfeminine Regimens, All
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.213 Transmasculine Regimens, Testosterone, Transdermal
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.214 Transmasculine Regimens, Testosterone, Parenteral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.215 Transmasculine Regimens, All
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.264 Heart Failure (CHF)_RxNorm
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.265 Heart Failure (CHF)_Clinical Condition Grouping
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.342 AFib (Atrial Fibrillation)_RxNORM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.344 AFib (Atrial Fibrillation)_Clinical Condition Grouping
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.348 COVID19 Vaccine_RxNorm
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.350 COVID19 Vaccine_Event Clinical Grouping
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.363 Statin Use_RxNorm
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.379 Estrogen Agonists Medications_RXNORM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.18 Medication Prescribable Brand Name
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1237.22 Medicinal Ingredients RXNORM
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119 Opioid Antagonist
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.120 Opioids
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.124 Immune Modulators
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.134 Central Nervous System Depressants
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.163 Antidepressants
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.164 Antihypertensives
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.170 Diuretics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.204 VTE Prophylaxis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.22 Anticoagulants for All Indications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.230 PO Antibacterials
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.231 Injectable Antifungals
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.260 Rivaroxaban Anticoagulant
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.262 Fondaparinux Anticoagulant
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.263 Dalteparin Anticoagulant
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.264 Heparin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.268 Enoxaparin Anticoagulant
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.2 Prescribable brand and generic non insulin drugs for hyperglycemia in Type 2 Diabetes
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.3 Prescribable brand and generic insulins and analogues
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.9 IgE Agonists, prescribable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.101 Systemic Cancer Directed Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.104 Erdafitinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.111 Prior Therapies for Erdafitinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.14 Endocrine Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.173 Non Opioid Analgesics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.174 Adjuvant Analgesics
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.179 Prior Therapies for Osimertinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.182 All Antineoplastic Agents
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.207 Osimertinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.208 Pemetrexed
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.219 Tepotinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.230 All Cancer Directed therapies
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.249 pralsetinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.250 Repotrectinib Value set
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.251 Amivantamab
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.252 Alectinib Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.253 Gemcitabine Drug Value set
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.254 vinorelbine Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.275 tarlatamab dlle
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.284 Binimetinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.285 Encorafenib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.292 Prior therapy for Amivantamab
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.293 ENHERTU Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.321 Prior_Systemic_therapy_Enhertu
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.326 Prior_systemic_therapy_Retevmo
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.327 Selpercatinib (Retevmo) Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.341 Aromatase_Inhibitor therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.342 Capivasertib_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.343 Fulvestrant_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.363 Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.364 Chemotherapy_breast_cancer
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.365 Cyclin_dependent_kinase
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.366 Taxane_Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.367 Endocrine_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.400 Fluoropyrimidine_CRC
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.401 Oxaliplatin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.402 Irinotecan_based_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.403 anti_VEGF_therapy_CRC
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.404 anti_EGFR_therapy_CRC
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.405 fruquitinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.419 Adagrasib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.420 cetuximab_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.421 Tamoxifen_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.436 Prior_therapy_Endometrial
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.437 Paclitaxel_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.441 Carboplatin_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.442 Durvalumab_therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.467 Prior_Systemic_therapy_Repotrectinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.47 Systemic treatment for endometrial cancer
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.470 Tamoxifen_Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.471 Toremifene_trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.472 Fulvestrant_Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.473 Elacestrant
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.474 Anastrozole_Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.475 Leuprolide_Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.476 Abemaciclib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.477 Palbociclib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.478 Ribociclib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.479 Carboplatin_Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.480 Cisplatin_Trodelvy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.481 Cyclophosphamide
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.482 Methotrexate
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.483 Gemcitabine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.484 Capecitabine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.485 Eribulin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.486 Doxorubicin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.487 Vinorelbine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.488 Epirubicin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.489 Ixabepilone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.490 Olaparib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.491 Talazoparib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.492 Entrectinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.493 larotrectinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.494 Alpelisib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.495 Capivasertib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.496 Pembrolizumab
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.497 Dostarlimab
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.498 Selpercatinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.499 Everolimus
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.500 Trastuzumab_deruxtecan
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.6 Orserdu
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.68 Jemperli
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.71 Platinum based therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.72 Prior Therapies for Tucatinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.73 Tucatinib
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.25 Antibiotic Usage for CAP Diagnosis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.29 Broad Spectrum Antibiotics for MDRO
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1264.8 Systemic Antimicrobials
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.91 Rho(D) Immune Globulin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.134 Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.200 Anticoagulant Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.201 Antithrombotic Therapy Anticoagulant
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.205 Direct Thrombin Inhibitor
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.211 Injectable Factor Xa Inhibitor for VTE Prophylaxis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.218 Unfractionated Heparin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.219 Low Molecular Weight Heparin for VTE Prophylaxis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.226 Thrombolytic tPA Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.232 Warfarin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.423 Statin Allergen
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.100 Injectable Fluorouracil
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101 Trastuzumab and Biosimilars
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.105 Long Acting Opioids
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.122 Carmustine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.123 Dacarbazine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.124 Streptozocin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.126 Alemtuzumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.127 Azacitidine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.128 Bendamustine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.129 Busulfan Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.130 Temozolomide Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.131 Thiotepa Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.132 Oxaliplatin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.133 Romidepsin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.134 Trabectedin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.135 Dolasetron Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.136 Dolasetron Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.137 Granisetron Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.138 Granisetron Transdermal
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.139 Granisetron Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.140 Ondansetron Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.141 Ondansetron Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.142 Ifosfamide Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.143 Arsenic Trioxide Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144 Netupitant Palonosetron Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.145 Fosnetupitant Palonosetron Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146 Aprepitant Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147 Rolapitant Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.148 Dexamethasone Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.149 Dexamethasone Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.151 Olanzapine Oral
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.152 Olanzapine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.153 Idarubicin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.154 Neurokinin 1 Receptor Antagonist Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.155 Serotonin Receptor Antagonist Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.156 Clofarabine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.157 Belinostat Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.158 Bortezomib Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.159 Cabazitaxel Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.160 Carfilzomib Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.161 Decitabine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.162 Elotuzumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.163 Enfortumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.164 Eribulin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.165 Etoposide Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.166 Inotuzumab Ozogamicin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.167 Mitoxantrone Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.168 Moxetumomab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.169 Necitumumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.170 Nelarabine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.171 Temsirolimus Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.172 Tisagenlecleucel Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.173 Topotecan Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.178 Atezolizumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.179 Avelumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.180 Bleomycin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.181 Cemiplimab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.182 Cladribine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.184 Durvalumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.185 Emapalumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.186 Fludarabine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.187 Ipilimumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.188 Nivolumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.189 Pembrolizumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.190 Polatuzumab Vedotin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.191 Pralatrexate Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.192 Vincristine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.193 Methotrexate Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.194 Trastuzumab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.195 Mitomycin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.196 Brentuximab Vedotin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.197 Doxorubicin Pegylated Liposomal Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.198 Blinatumomab Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.199 Trastuzumab Emtansine Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.200 Gemtuzumab Ozogamicin Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.201 Tagraxofusp Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.202 Axicabtagene Ciloleucel Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.222 High Emetic Risk Intravenous Antineoplastic Agent
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.223 Moderate Emetic Risk Intravenous Antineoplastic Agent
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.224 Docetaxel Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.225 Cyclophosphamide Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.226 LAG 3 Inhibitor
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.200 Doxorubicin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.201 Epirubicin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.202 Capecitabine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.203 Cyclophosphamide
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.204 Injectable Fluorouracil
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.205 Methotrexate
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206 Trastuzumab and Biosimilars
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.208 Carboplatin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.210 Long Acting Opioids
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.212 Dexamethasone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.213 Olanzapine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.228 Low Emetic Risk Intravenous Antineoplastic Agent
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.229 Minimal Emetic Risk Intravenous Antineoplastic Agent
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.238 First Line Drug Therapy for Metastatic Colorectal Cancer
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.242 High Emetic Risk Intravenous Antineoplastic Agent
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.243 Moderate Emetic Risk Intravenous Antineoplastic Agent
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.244 Anthracycline Injectable
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.245 Antiemetic Agent
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.11 Oxycodone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.12 Oxymorphone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.70 Morphine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.71 Methadone Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.72 Meperidine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.73 Levorphanol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.74 Hydromorphone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.75 Hydrocodone
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.76 Fentanyl
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.77 Codeine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.12 Butorphanol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.13 Dihydrocodeine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.14 Nalbuphine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.15 Opium Combinations
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.16 Pentazocine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.17 Tapentadol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1004.18 Tramadol
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4019 Fibrinolytic Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4045 Oral Anticoagulant Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1043 Potentially Harmful Antihistamines for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1044 Reserpine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1045 Reserpine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1049 Potentially Harmful Antiparkinsonian Agents for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050 Potentially Harmful Gastrointestinal Antispasmodics for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1051 Dipyridamole Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1053 Nifedipine Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1054 Potentially Harmful Antidepressants for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1055 Potentially Harmful Barbiturates for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1057 Meprobamate Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1058 Potentially Harmful Estrogens for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1059 Potentially Harmful Sulfonylureas for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1060 Desiccated Thyroid Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1062 Potentially Harmful Skeletal Muscle Relaxants for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1063 Potentially Harmful Pain Medications for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1065 Digoxin Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1066 Digoxin Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1067 Doxepin Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1068 Doxepin Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1149 Substance Use Disorder Long Acting Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150 Substance Use Disorder Short Acting Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1170 Atomoxetine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1171 Clonidine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1172 Dexmethylphenidate
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1173 Dextroamphetamine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1174 Lisdexamfetamine
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1176 Methylphenidate
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1190 Antibiotic Medications for Upper Respiratory Infection
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1247 Megestrol Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1248 Meperidine Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1249 Potentially Harmful Antidepressants for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1250 Potentially Harmful Antihistamines for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1251 Potentially Harmful Antiparkinsonian Agents for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1252 Potentially Harmful Barbiturates for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1253 Potentially Harmful Estrogens for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1254 Potentially Harmful Gastrointestinal Antispasmodics for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1255 Potentially Harmful Pain Medications for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1256 Potentially Harmful Skeletal Muscle Relaxants for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1257 Potentially Harmful Sulfonylureas for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1258 Substance Use Disorder Long Acting Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259 Substance Use Disorder Short Acting Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1001 Antibiotic Medications for Pharyngitis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1078 Nifedipine Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1080 Contraceptive Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1109 Meperidine Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1129 Desiccated Thyroid Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1143 Isotretinoin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1167 Dipyridamole Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1205 Leucovorin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1211 Aspirin and Other Antiplatelets
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1252 Guanfacine Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1255 Megestrol Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1256 Meprobamate Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1266 Aromatase Inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1267 Glucocorticoids (oral only)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1481 Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1482 Potentially Harmful Antiinfectives for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1517 Dementia Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1530 Antidepressant Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1531 Potentially Harmful Benzodiazepines for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1532 Potentially Harmful Antipsychotics for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1001 Antibiotic Medications for Pharyngitis
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1080 Contraceptive Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1143 Isotretinoin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1205 Leucovorin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1211 Aspirin and Other Antiplatelets
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1213 Antidepressant Medication
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1265 Aromatase Inhibitors
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1266 Glucocorticoids (oral only)
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1480 Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1481 Potentially Harmful Antiinfectives for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1510 Dementia Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1522 Potentially Harmful Benzodiazepines for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1523 Potentially Harmful Antipsychotics for Older Adults
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.1577 Pharmacologic Therapy for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.133 Beta Blocker Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1342 Beta Blocker Therapy for LVSD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1921 Beta Blocker Therapy Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1926 ACE Inhibitor or ARB or ARNI Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.3000 Metformin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.39 ACE Inhibitor or ARB or ARNI
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.423 Tobacco Use Cessation Pharmacotherapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1139 ACE Inhibitor or ARB or ARNI
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1174 Beta Blocker Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1184 Beta Blocker Therapy for LVSD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1190 Tobacco Use Cessation Pharmacotherapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1489 ACE Inhibitor or ARB or ARNI Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1493 Beta Blocker Therapy Ingredient
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1561 Medications for Above Normal BMI
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1562 Medications for Below Normal BMI
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1566 Adult Depression Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1567 Adolescent Depression Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1572 High Intensity Statin Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1574 Low Intensity Statin Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1575 Moderate Intensity Statin Therapy
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.3000 Metformin
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1498 Medications for Above Normal BMI
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1499 Medications for Below Normal BMI
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1476 Pharmacologic Therapy for Hypertension
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.469 Adolescent Depression Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.470 Adult Depression Medications
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.16 Medication Brand Name
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.17 Medication Clinical General Drug
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3183 NHSNSkinPreparationCode
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3360 NHSNAntimicrobialAgentAURPCode

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem v3-rxNorm

Language: en

This case-sensitive code system http://www.nlm.nih.gov/research/umls/rxnorm defines codes, but no codes are represented here

Source

{
  "resourceType" : "CodeSystem",
  "id" : "v3-rxNorm",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem v3-rxNorm</b></p><a name=\"v3-rxNorm\"> </a><a name=\"hcv3-rxNorm\"> </a><a name=\"v3-rxNorm-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p></div><p>This case-sensitive code system <code>http://www.nlm.nih.gov/research/umls/rxnorm</code> defines codes, but no codes are represented here</p></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/codesystem-properties-mode",
      "valueCode" : "not-present"
    }
  ],
  "url" : "http://www.nlm.nih.gov/research/umls/rxnorm",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.6.88"
    }
  ],
  "version" : "3.0.1",
  "name" : "RxNorm",
  "title" : "RxNorm",
  "status" : "active",
  "experimental" : false,
  "date" : "2020-11-03",
  "publisher" : "National Library of Medicine (NLM)",
  "contact" : [
    {
      "name" : "National Library of Medicine (NLM)",
      "telecom" : [
        {
          "system" : "email",
          "value" : "rxnorminfo@nlm.nih.gov"
        }
      ]
    }
  ],
  "description" : "RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software, including those of First Databank, Micromedex, and Gold Standard Drug Database. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary. RxNorm now includes the United States Pharmacopeia (USP) Compendial Nomenclature from the United States Pharmacopeial Convention. USP is a cumulative data set of all Active Pharmaceutical Ingredients (API).",
  "copyright" : "Using RxNorm codes of type SAB=RXNORM as this specification describes does not require  a UMLS license. Access to the full set of RxNorm definitions, and/or additional use of other RxNorm structures and information requires a UMLS license. The use of RxNorm in this specification is pursuant to HL7's status as a licensee of the NLM UMLS. HL7's license does not convey the right to use RxNorm to any users of this specification; implementers must acquire a license to use RxNorm in their own right.",
  "caseSensitive" : true,
  "content" : "not-present"
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.